Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 79, Issue 3, 2008, Pages 438-445

  Kakehashi, Akihiro ^a   Inoda, Shigeru ^a   Mameuda, Chiho ^a   Kuroki, Masatoshi ^a   Jono, Tadashi ^b   Nagai, Ryuji ^b   Horiuchi, Seikoh ^b   Kawakami, Masanobu ^a   Kanazawa, Yasunori ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AGE; Diabetes; Diabetic retinopathy; Macrophage; VEGF; VEGF receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRIS; MACROPHAGE; RETINA; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 39449099625     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.018     Document Type: Article

References (28)

1. Adamis A.P., Miller J.W., Bernal M.T., D'amico D.J., Folkman J., Yeo T.K., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118 (1994) 445-450
2. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10457-10461
3. Tolentino M.J., Miller J.W., Gragoudas E.S., Jakobiec F.A., Flynn E., Chatzistefanou K., et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103 (1996) 1820-1828
4. Treins C., Giorgetti-Peraldi S., Murdaca J., and Van Obberghen E. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J. Biol. Chem. 276 (2001) 43836-43841
5. Murata T., Nagai R., Ishibashi T., Inomuta H., Ikeda K., and Horiuchi S. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40 (1997) 764-769
6. Bhisitkul R.B., Robinson G.S., Moulton R.S., Claffey K.P., Gragoudas E.S., and Miller J.W. An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization. Arch. Ophthalmol. 123 (2005) 214-219
7. Hammes H.P., Alt A., Niwa T., Clausen J.T., Bretzel R.G., Brownlee M., et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42 (1999) 728-736
8. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331 (1994) 1480-1487
9. Sone H., Kawakami Y., Okuda Y., Sekine Y., Honmura S., Matsuo K., et al. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40 (1997) 726-730
10. Joussen A.M., Poulaki V., Qin W., Kirchhof B., Mitsiades N., Wiegand S.J., et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160 (2002) 501-509
11. Miyamoto K., Hiroshiba N., Tsujikawa A., and Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2190-2194
12. Ishida S., Yamashiro K., Usui T., Amano S., Ogura Y., Hida T., et al. Significance of leukocytes in the regulation of retinal edema, ischemia, and angiogenesis. Nippon Ganka Gakkai Zasshi 108 (2004) 193-201
13. Ishida S., Yamashiro K., Usui T., Kaji Y., Ogura Y., Hida T., et al. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat. Med. 9 (2003) 781-788
14. Esser P., Heimann K., and Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br. J. Ophthalmol. 77 (1993) 731-733
15. Yoshida S., Yoshida A., Ishibashi T., Elner S.G., and Elner V.M. Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J. Leukoc. Biol. 73 (2003) 137-144
16. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18 (2004) 1450-1452
17. Miyamoto K., Khosrof S., Bursell S.E., Rohan R., Murata T., Clermont A.C., et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10836-10841
18. Horiuchi S., Araki N., and Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J. Biol. Chem. 266 (1991) 7329-7332
19. Sone H., Kawakami Y., Okuda Y., Kondo S., Hanatani M., Suzuki H., et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem. Biophys. Res. Commun. 221 (1996) 193-198
20. Meleth A.D., Agron E., Chan C.C., Reed G.F., Arora K., Byrnes G., et al. Serum inflammatory markers in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4295-4301
21. Lu M., Kuroki M., Amano S., Tolentino M., Keough K., Kim I., et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest. 101 (1998) 1219-1224
22. Endo M., Yanagisawa K., Tsuchida K., Okamoto T., Matsushita T., Higuchi M., et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm. Metab. Res. 33 (2001) 317-322
23. Matsumoto Y., Takahashi M., and Ogata M. Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy. Jpn. J. Ophthalmol. 46 (2002) 406-412
24. Funatsu H., Yamashita H., Noma H., Mimura T., Nakamura S., Sakata K., et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch. Clin. Exp. Ophthalmol. 243 (2005) 3-8
25. Suzuma K., Takagi H., Otani A., Suzuma I., and Honda Y. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc. Res. 56 (1998) 183-191
26. Hammes H.P., Lin J., Bretzel R.G., Brownlee M., and Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47 (1998) 401-406
27. Yokoi M., Yamagishi S.I., Takeuchi M., Ohgami K., Okamoto T., Saito W., et al. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br. J. Ophthalmol. 89 (2005) 673-675
28. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort, Diabetes Care 22 (1999) 99-111.